senktide,
substance P (6-11), succinyl-Asp(6)-Me-Phe(8)-,
substance P (6-11), succinyl-aspartyl(6)-methylphenylalanine(8)-,
succinyl-6-Asp-8-Me-Phe-substance P (6-11),
Senktide,
106128-89-6,
CHEMBL106124,
Succinyl-6-asp-8-Me-phe-substance P (6-11),
Substance P (6-11), succinyl-asp(6)-Me-phe(8)-,
Substance P (6-11), succinyl-aspartyl(6)-methylphenylalanine(8)-,
(3S)-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[(4-hydroxy-4-oxobutanoyl)amino]-4-oxobutanoic acid,
4-10-Neuromedin B (swine spinal cord), N-(3-carboxy-1-oxopropyl)-6-(N-methyl-L-phenylalanine)-7-de-L-valine-,
L-Methioninamide, N-(3-carboxy-1-oxopropyl)-L-alpha-aspartyl-L-phenylalanyl-N-methyl-L-phenylalanylglycyl-L-leucyl-,
N-(3-Carboxy-1-oxopropyl)-6-(N-methyl-L-phenylalanine)-7-de-L-valine-4-10-neuromedin B (swine spinal cord),
AC1L33FH,
GTPL2127,
SCHEMBL5238634,
CTK8E9092,
suc[Asp6,MePhe3]SP(6-11),
HY-P0187,
suc[Asp6,MePhe3]SP(6-11)),
BDBM50052524,
ZINC95615286,
AKOS027301460,
CS-8091,
LS-96168,
RT-015687,
B6580,
A16945,
J-001543,
(S)-N-((S)-1-{[(S)-1-({[(S)-1-((S)-1-Carbamoyl-3-methylsulfanyl-propylcarbamoyl)-3-methyl-butylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-2-phenyl-ethyl)-3-(3-carboxy-propionylamino)-succinamic acid,
Natalizumab,
Tysabri,
D05ZWG,
CID108147,
ACN-040101,
C054724,
189261-10-7,